scispace - formally typeset
Search or ask a question
Institution

Inova Fairfax Hospital

HealthcareFalls Church, Virginia, United States
About: Inova Fairfax Hospital is a healthcare organization based out in Falls Church, Virginia, United States. It is known for research contribution in the topics: Population & Nonalcoholic fatty liver disease. The organization has 1227 authors who have published 1979 publications receiving 100143 citations. The organization is also known as: Fairfax Hospital.


Papers
More filters
Journal ArticleDOI
TL;DR: As the global epidemic of obesity fuels metabolic conditions, the clinical and economic burden of NAFLD will become enormous, and random‐effects models were used to provide point estimates of prevalence, incidence, mortality and incidence rate ratios.

6,746 citations

Journal ArticleDOI
TL;DR: The large number of patients with NAFLD with potential for progressive liver disease creates challenges for screening, as the diagnosis of NASH necessitates invasive liver biopsy.
Abstract: NAFLD is one of the most important causes of liver disease worldwide and will probably emerge as the leading cause of end-stage liver disease in the coming decades, with the disease affecting both adults and children. The epidemiology and demographic characteristics of NAFLD vary worldwide, usually parallel to the prevalence of obesity, but a substantial proportion of patients are lean. The large number of patients with NAFLD with potential for progressive liver disease creates challenges for screening, as the diagnosis of NASH necessitates invasive liver biopsy. Furthermore, individuals with NAFLD have a high frequency of metabolic comorbidities and could place a growing strain on health-care systems from their need for management. While awaiting the development effective therapies, this disease warrants the attention of primary care physicians, specialists and health policy makers.

3,076 citations

Journal ArticleDOI
TL;DR: Aliment Pharmacol Ther 2011; 34: 274–285
Abstract: SUMMARY Background Non-alcoholic fatty liver disease (NAFLD) is a common cause of chronic liver disease, and its worldwide prevalence continues to increase with the growing obesity epidemic. This study assesses the epidemiology of NAFLD in adults based on clinical literature published over the past 30 years. Aim To review epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults based on clinical literature published over the past 30 years. Methods An in-depth search of PubMed (1980–2010) was based on five search terms: ‘nonalcoholic fatty liver disease’ OR ‘non-alcoholic steatohepatitis’ OR ‘fatty liver’ OR ‘steatosis’ AND ‘incidence’ [MeSH Terms] OR ‘prevalence’ [MeSH Terms] OR ‘natural history’. Studies of paediatric cohorts were excluded. Articles were categorised by topic and summarised, noting generalisations concerning their content.

2,679 citations


Authors

Showing all 1249 results

NameH-indexPapersCitations
Lance A. Liotta153832102335
Christopher M. O'Connor13489470357
Vivette D. D'Agati11152746487
Zobair M. Younossi10675962073
Randall T. Higashida9642945856
Emanuel F. Petricoin9348836145
Zachary Goodman8630241964
Guadalupe Garcia-Tsao8133130577
Bruce R. Bacon7841031928
Paul A. Gurbel7758928852
Thomas P. Conrads6820218375
Loren Lipworth5721612143
Lynn H. Gerber5621411459
Steven D. Nathan5129611856
Juan R. Cebral502159089
Network Information
Related Institutions (5)
Cedars-Sinai Medical Center
26.4K papers, 1.2M citations

89% related

Cleveland Clinic
79.3K papers, 3.4M citations

89% related

Mayo Clinic
169.5K papers, 8.1M citations

89% related

Rush University Medical Center
29K papers, 1.3M citations

89% related

Vanderbilt University Medical Center
34.6K papers, 1.1M citations

88% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
20236
202229
2021149
2020120
2019144
2018124